Literature DB >> 2170567

Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA.

A Rhodes1, W James.   

Abstract

Antisense RNA, which has a sequence complementary to mRNA, may provide the basis for antiviral therapies of high selectivity. We have explored the inhibitory effect of six antisense RNAs upon the replication of human immunodeficiency virus (HIV) in cell culture. We chose regions of the HIV genome to test whether sequences required for splicing or for translation initiation were more susceptible to antisense RNA interference. Our results suggest that inhibitory antisense RNAs contain sequences complementary to the AUG initiation codon of the tat gene and have a comparatively low tendency to form intramolecular base pairs which would interfere with intermolecular duplex formation. Inhibition can be substantial (over 70%) but is transient. Transience does not result from mutation of the input virus. Inhibition was not a consequence of the induction of interferon by antisense RNA-mRNA duplex formation. Our results suggest that at least part of the inhibitory effect is at the posttranscriptional level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170567     DOI: 10.1099/0022-1317-71-9-1965

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  23 in total

Review 1.  Gene therapy for HIV.

Authors:  A M Lever
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

Review 2.  Gene therapy for infectious diseases.

Authors:  B A Bunnell; R A Morgan
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Inhibition of human immunodeficiency virus replication by the herpes simplex virus virion host shutoff protein.

Authors:  T Hamouda; R McPhee; S C Hsia; G S Read; T C Holland; S R King
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model.

Authors:  A Carnero; J D Hudson; G J Hannon; D H Beach
Journal:  Nucleic Acids Res       Date:  2000-06-01       Impact factor: 16.971

5.  A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus.

Authors:  M Federico; F Nappi; G Ferrari; C Chelucci; F Mavilio; P Verani
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 6.  Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).

Authors:  E Sandström; B Oberg
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

7.  A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection.

Authors:  M A Biasolo; A Radaelli; L Del Pup; E Franchin; C De Giuli-Morghen; G Palu
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1.

Authors:  K Rittner; C Burmester; G Sczakiel
Journal:  Nucleic Acids Res       Date:  1993-03-25       Impact factor: 16.971

9.  Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1.

Authors:  M Homann; S Tzortzakaki; K Rittner; G Sczakiel; M Tabler
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

10.  Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments.

Authors:  T A Holzmayer; D G Pestov; I B Roninson
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.